Annovis Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.About ANVS
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases.
CEOMaria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees8
Employees8
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2008
Founded2008
Employees8
Employees8
ANVS Key Statistics
Market cap97.45M
Market cap97.45M
Price-Earnings ratio-2.47
Price-Earnings ratio-2.47
Dividend yield—
Dividend yield—
Average volume791.09K
Average volume791.09K
High today$3.74
High today$3.74
Low today$3.46
Low today$3.46
Open price$3.68
Open price$3.68
Volume872.65K
Volume872.65K
52 Week high$5.60
52 Week high$5.60
52 Week low$1.11
52 Week low$1.11
Stock Snapshot
The current Annovis Bio(ANVS) stock price is $3.62, with a market capitalization of 97.45M. The stock trades at a price-to-earnings (P/E) ratio of -2.47.
During the trading session on 2025-12-19, Annovis Bio(ANVS) shares reached a daily high of $3.74 and a low of $3.46. At a current price of $3.62, the stock is +4.5% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 872.65K, compared to an average daily volume of 791.09K.
Over the past 52 weeks, Annovis Bio(ANVS) stock has traded between a high of $5.60 and a low of $1.11.
Over the past 52 weeks, Annovis Bio(ANVS) stock has traded between a high of $5.60 and a low of $1.11.
People also own
Based on the portfolios of people who own ANVS. This list is generated using Robinhood data, and it’s not a recommendation.